Cytogenetic analysis confirming t(8;9)(p22;p24) and RNA sequencing detecting a PCM1::JAK2 fusion were crucial to revise diagnosis to MLN-eo-TK with PCM1::JAK2 presenting as B-ALL in the blast phase. The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.